C8orf33

Across TCGA pan-cancer cohorts, C8orf33 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of C8orf33’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where C8orf33 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types C8orf33 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

COAD, LUAD, and LSCC are the cancer types where C8orf33 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in C8orf33 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	+0.691	<.001	10	view →
LUAD	Male	II,III,IV	+0.526	<.001	8	view →
LSCC	All	II,III,IV	+0.399	<.001	8	view →
HNSC	All	III,IV	+0.320	<.001	8	view →
CCRCC	Male	II,III,IV	+0.351	<.001	6	view →
PDAC	All	All	−0.294	<.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

C8orf33–COAD

Open the COAD breakdown →